Fda (Photo credit: Wikipedia)
The Food and Drug Administration will hold a two-day meeting
in June to discuss growing safety concerns about metal-on-metal hip
replacements, which recent studies suggest are more likely to fail than
traditional plastic hips.
Metal hip joints have been under scrutiny due to reports of
pain and swelling that have sometimes required removal. In 2010, Johnson
& Johnson recalled roughly 93,000 implants. The FDA already asked
device companies to conduct additional follow-up studies to monitor problems
with the implants.
The agency says it will hold a two-day meeting beginning
June 27 to consider whether more rigorous testing standards are needed.
Earlier this month, British experts said doctors should stop
using metal hip joints because data show they have to fixed or replaced more
often than older implants.